TUMEURS BRONCHOPULMONAIRES

TUMEURS BRONCHOPULMONAIRES
CARCINOMES A PETITES CELLULES
•
Aisner J. Extensive-disease small- cell lung cancer : the thrill of victory ; the
agony of defeat. J Clin Oncol 1996, 14 : 658-65.
•
Ettinger DS, Finkelstein DM, Abeloff MD, Skeel RT, Stott PB, Frontiera MS,
Bonomi PD. Justification for evaluating new anticancer drugs selected in
untreated patients with extensive stage small cell lung cancer : an Eastern
Cooperative Oncology Group randomized study. J Natl Cancer Inst 1992,
84:1077-84.
•
Fox W, Scadding JG . Medical Research Council Comparative trial of surgery and
radiotherapy for primary treatment of small celled or oat celled carcinoma of
bronchus. Ten years follow-up. Lancet 1973, 2: 63-5.
•
Johnson BE, Cortazar P, Chute JP. Second lung cancers in patients successfully
treated for lung cancer. Semin Oncol 1997, 24:1-9.
•
Luce S, Paesmans M, Berghmans T, Castaigne C, Sotiriou C, Vermylen P,
Sculier JP. Revue critique des études randomisées évaluant le rôle de la
radiothérapie thoracique adjuvante à la chimiothérapie dans le traitement du
cancer bronchique à petites cellules au stade limité. Rev Mal Resp 1998, 15 :
633-641.
•
Nichols CR, Fox EP, Roth BJ, Williams SD, Loehrer PJ, Einhorn LH. Incidence of
neutropenic fever in patients treated with standard-dose combination
chemotherapy for small-cell lung cancer and the cost impact of treatment with
granulocyte colony-stimulating factor. J Clin Oncol 1994, 12 :1245-50.
•
Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin
O, Joss RA, Kies MS, Lebeau B, OnoshI T, Osterlind K, Tattersall MHN, Wagner
H.A Meta-analysis of thoracic radiotherapy for small cell lung cancer. N Engl J
Med 1992, 327:1618-24.
•
Pujol JL, Douillard JY, Riviere A, Quoix E, Lagrange JL, Berthaud P, BardonnetComte M, Polin V, Gautier V, Milleron B, Chomy F, Chomy P, Spaeth D, Le
Chevalier T. Dose-intensity of a four-drug chemotherapy regimen with or without
recombinant human granulocyte-macrophage colony-stimulating factor in
extensive-stage small-cell lung cancer : a multicenter randomized phase III study.
J Clin Oncol 1997, 15 :2082-2089
•
Sculier JP, Berghmans T, Castaigne C, Luce S, Sotiriou C, Vermylen P,
Paesmans M. Maintenance chemotherapy for small cell lung cancer: a critical
review of the literature. Lung Cancer 1998, 19: 141-151.
•
Sculier JP, Evans WK, Feld R, De Boer G, Payne DG, Shepherd FA, Pringle JF,
Yeoh JL, Quirt IC, Curtis JE, Herman JG. Superior vena caval obstruction
syndrome in small cell lung cancer. Cancer 1986, 57 : 847-851.
•
Shepherd FA, Ginsberg RJ, Haddad R, Feld R, Sagman U, Evans WK, DeBoer
G, Maki E. Importance of clinical staging in limited small-cell lung cancer: a
valuable system to separate prognostic subgroup. J Clin Oncol 1993, 11: 15921597.
•
Steward WP, Von Pawel J, Gatzemeier U, Woll P, Thatcher N, Koschel G, Clancy
L, Verweij J, De Wit R, Pfeifer W, Fennelly J, Von Eiff M, Frisch J. Effects of
granulocyte-macrophage colony-stimulating factor and dose-intensification of VICE chemotherapy in small-cell lung cancer : a prospective randomized study of
300 patients. J Clin Oncol 1998 ; 16 :642-50.
•
Warde P, Payne D. Does thoracic irradiation improve survival and local control in
limited stage small cell carcinoma of the lung ? A meta-analysis.J Clin Oncol
1992, 10: 890-5.
•
World Health Organisation. Histological typing of lung and pleural tumors. 3rd ed.
World Health Organisation, Geneva, 1998.
•
Zelen M. Keynote address on biostatistics and data retrieval. Cancer Treat Rep
1973, 4: 31-42.
CARCINOMES NON A PETITES CELLULES
•
Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M,
Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P,
Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB,
Taskinen E, Erozan Y, Greenwald P, Huttunen JK. Alpha-Tocopherol and
beta-carotene supplements and lung cancer incidence in the alpha-tocopherol,
beta-carotene cancer prevention study: effects of base-line characteristics and
study compliance. J Natl Cancer Inst 88 (21): 1560-70, 1996.
•
Depierre A, Bosset J, Jacoulet P. Principes et traitements par chimiothérapie et
radiothérapie des cancers bronchiques primitifs. In: Elsevier, ed. Encycl Méd Chir.
Vol. Pneumologie, 6-002-L-10. Paris, pp. 1-10, 1998.
•
Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR,
Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Lack of effect
of long-term supplementation with beta carotene on the incidence of malignant
neoplasms and cardiovascular disease. N Engl J Med 334 (18): 1145-9, 1996.
•
Hill C. Let's stop using packet-years as expression of tobacco consumption
(editorial). Rev Mal Respir 9 (6): 573-4, 1992.
•
Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E, Aromaa A.
Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am
J Epidemiol 146 (3): 223-30, 1997.
•
Ménégoz F, Black RJ, Arveux P, Magne V, Ferlay J, Buémi A, Carli PM,
Chapelain G, Faivre J, Gignoux M, Grosclaude P, Macé-Lesec'h J, Raverdy N,
Schaffer P. Cancer incidence and mortality in France in 1975-1995. Europ J
Cancer Prev 6: 442-466, 1997.
•
Moutain CF. Revision of international system for staging Lung Cancer. Chest 111:
17101717, 1997.
•
Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell
lung cancer: a meta-analysis using updated data on individual patients from 52
randomised clinical trials. BMJ 311: 899-909, 1995.
•
Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh
JP, Meyskens FL, Jr., Valanis B, Williams JH, Jr., Barnhart S, Cherniack MG,
Brodkin CA, Hammar S. Risk factors for lung cancer and for intervention effects in
CARET, the BetaCarotene and Retinol Efficacy Trial. J Natl Cancer Inst 88 (21):
1550-9, 1996.
•
Pastorino U, Infante M, Maioli M, Chiesa G, Buyse M, Firket P, Rosmentz N,
Clerici M, Soresi E, Valente M, et al. Adjuvant treatment of stage I lung cancer
with high-dose vitamin A . J Clin Oncol 11 (7): 1216-22, 1993.
•
PORT Metaanalysis Trialists Group. Postoperative radiotherapy in non-small-cell
lung cancer: systematic review and metaanalysis of individual patient data from
nine randomised controlled trials. Lancet 352 (9124): 257-63, 1998.
•
Quoix E, Moro D, Jacoulet P, Miech G, Robinet G, Vaylet F, Vincent M, Grivaux
M, Leclerc P, Coudert B, Breton JL, Souquet PJ, Charloux A, on behalf of the
'Groupe d'Oncologie Thoracique de Langue Française". Long term survivors in
non resected non small cell lung cancer (NSCLC) patients: A french data base.
Proc Am Soc Clin Oncol 14 (Al 130): 368, 1995.
CANCERS BRONCHOPULMONAIRES SECONDAIRES
•
Depierre A. Cancers broncho-pulmonaires secondaires. Etiologie et diagnostic.
Rev Prat 1990, 40 : 267-269.
•
Filderman A, Coppage L, Shaw C, Matthay R. Pulmonary and pleural
manifestations of extrathoracic malignancies. Clinics in Chest Medicine 1989,
10(4) :747-807
•
Luce J Metastatic malignant tumors. Murray, Nadel. Textbook of repiratory
medicine. Second ed., WB Saunders company, San francisco, 1994.
•
Matthay R, Arroliga A. Resection of pulmonary metastases. Am Rev Respir Dis
1993, 148 : 1691-1696.
•
Milleron B., Capron F., Calais G., Mangiapan G., Rosencher L ., Wdowick A.,
Dromer C., Lemarié E. Cancers bronchopulmonaires secondaires. Encycl ; Med.
Chir. (Elsevier, Paris) Pneumologie 6-0002
•
Shepherd M. Endobronchial metastatic disease. Thorax 1982, 37 : 362-365.
TUMEURS BRONCHOPULMONAIRES NON CANCEREUSES
•
Arrigoni M., Woolner L., Bernatz P., Miller E., Fontana R. Benign tumors of the
lung. A ten-years surgical experience. J. Thorac. Cardiovasc. Surg. 1970, 60 :
589-599.
•
Hurt R. Benign tumours of the bronchus and trachea, 1951-1981.Annals of the
Royal College of Surgeons of England 1984, 65 : 22-26.
•
Hurt R, Bates M. Carcinoid tumours of the bronchus : a 33 year experience.
Thorax 1984, 39 : 617-623.
•
Madewell J, Feigin D. Benign tumors of the lung. Seminars in Roentgenology
1977, 3 : 175-186.
•
Van den Bosch J, Wagenaar S, Corrin B, Elbers J, Knaepen P, Westermann C.
Mesenchymoma of the lung (so called hamartoma) : a review of 154 parenchymal
and endobronchial cases. Thorax 1987, 42 : 790-793.
TRAITEMENTS SYMPTOMATIQUES DES CANCERS BRONCHOPULMONAIRES
•
Aaronson N., Ahmedzai S, Bergman B. et al. The european organisation for
research and treatment of cancer QLQ C30 : a quality of life instrument for use in
international clinical trials in oncology. JNCI 1993, 85 : 365-376.
•
Bergman B., Sullivan M., Sorenson S. Quality of life during chemotherapy for
small cell lung cancer. Acta Oncologica 1992, 31 (1) : 19-28.
•
Cella D., Tulsky D., Gray G. et al. The functional assessment of lung cancer
therapy scale :development and validation of a general measure. J. Clin. Oncol.
1993, 11 : 570-579.
•
Grunberg S., Hesketh P. Control of chemotherapy induced emesis N Engl J Med
1993, 329 : 1790-1796.
•
Levy M. Pharmacologic treatment of cancer pain N Engl J Med 1996, 335 : 11241132.
•
L’Her P., Natali F. Traitement de confort des tumeurs bronchopulmonaires. In :
Milleron B., Depierre A. Cancers bronchopulmonaires. Arnette 1998, 415-422.
•
Muers M . Quality of life and symptom control In : Eur Respir Mon. 1995, 1 :1,
361-394.
•
Portenoy R. , Lesage P. Management of cancer pain. The Lancet 1999, 353 :
1695-1700.